-transparent.png){kind=logo}
Tumor-derived transforming growth factors (TGF) have been proposed as possible mediators of hypercalcemia in malignancy. We have studied the action of recombinant human TGF-alpha in cultured bone cells and in bone explant cultures. In clonal UMR-106 rat osteosarcoma cells, TGF-alpha and epidermal growth factor (EGF) were equipotent in binding to the EGF receptor. TGF-alpha and EGF both stimulated resorption of neonatal mouse calvaria, and maximal responses were obtained with 10 ng/ml of TGF-alpha after 72 h in culture. The effects of both TGF-alpha and EGF in calvaria, but not those of parathyroid hormone, were inhibited by 5 X 10(-7) M indomethacin. Fetal rat limb bone cultures were less sensitive to TGF-alpha than neonatal mouse calvaria, with a concentration of 30 ng/ml being required to stimulate resorption in this system. The bone-resorbing activity of TGF-alpha in fetal rat bones was inhibited by 10 ng/ml calcitonin but not by 5 X 10(-7) M indomethacin. EGF at concentrations up to 300 ng/ml did not stimulate resorption of the limb bones at time periods up to 66 h. The results indicate that human TGF-alpha is a potent bone-resorbing agent, and support the concept that this growth factor exhibits some effects distinct from those of EGF. TGF-alpha could play an etiologic role in the hypercalcemia of malignancy.
P H Stern, and
N S Krieger, and
R A Nissenson, and
R D Williams, and
M E Winkler, and
R Derynck, and
G J Strewler
April 1986,
Proceedings of the National Academy of Sciences of the United States of America,
P H Stern, and
N S Krieger, and
R A Nissenson, and
R D Williams, and
M E Winkler, and
R Derynck, and
G J Strewler
May 1985,
Science (New York, N.Y.),
P H Stern, and
N S Krieger, and
R A Nissenson, and
R D Williams, and
M E Winkler, and
R Derynck, and
G J Strewler
January 2000,
Andrologia,
P H Stern, and
N S Krieger, and
R A Nissenson, and
R D Williams, and
M E Winkler, and
R Derynck, and
G J Strewler
November 1988,
Endocrinology,
P H Stern, and
N S Krieger, and
R A Nissenson, and
R D Williams, and
M E Winkler, and
R Derynck, and
G J Strewler
May 1988,
International journal of cell cloning,
P H Stern, and
N S Krieger, and
R A Nissenson, and
R D Williams, and
M E Winkler, and
R Derynck, and
G J Strewler
October 1995,
Bone,
P H Stern, and
N S Krieger, and
R A Nissenson, and
R D Williams, and
M E Winkler, and
R Derynck, and
G J Strewler
June 1996,
Endocrinology,
P H Stern, and
N S Krieger, and
R A Nissenson, and
R D Williams, and
M E Winkler, and
R Derynck, and
G J Strewler
January 1983,
Nature,
P H Stern, and
N S Krieger, and
R A Nissenson, and
R D Williams, and
M E Winkler, and
R Derynck, and
G J Strewler
July 1994,
Biochemistry and molecular biology international,
P H Stern, and
N S Krieger, and
R A Nissenson, and
R D Williams, and
M E Winkler, and
R Derynck, and
G J Strewler
November 1996,
Journal of endocrinological investigation,
